|Articles|April 15, 2016
- Gastrointestinal Special Issue
- Volume 1
- Issue 1
Medical Illustration: Targeting HER2 in Gastric Cancer
Author(s)Erin Moore
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Advertisement
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Articles in this issue
almost 10 years ago
In Gastroesophageal Cancers, Better Prevention and Treatments Neededalmost 10 years ago
The Next Frontier: The Promise of Immunotherapy in Gastrointestinal Cancersalmost 10 years ago
Right in the Gut: New Clues About Preventing and Treating Gastric Canceralmost 10 years ago
An Insight Into Gastric Cancers and Life Without a Stomachalmost 10 years ago
Changing Lives With ImmunotherapyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC
2
The Emotional Side of Cancer Care Beyond Medical Treatment
3
Besremi Recognized by Updated Guidelines for Essential Thrombocythemia
4
Beyond Statistics: Lessons in Mindset and Action from a Cancer Survivor
5